Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Red blood cell ATP export and transfusion in sepsis

Award Number: R01HL161071
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/05/2023
PERIOD OF PERFORMANCE END DATE: 12/31/2026

Group Awards By:

View Award Description

Red blood cell ATP export and transfusion in sepsis - ABSTRACT O2 uptake in the lung and O2 delivery peripherally depend on the efficient matching of blood flow to regional O2 availability in the lung and O2 consumption in tissues. To achieve this matching, red blood cell (RBC) hemoglobin allostery regulates not only trans-erythrocytic O2 flux but also RBC export of vasoactive mediators that respond to O2 demand. RBCs export vasoregulatory ATP basally and in response to O2 deficit. This RBC-based vascular control of the uptake and delivery of O2 may be disrupted by endogenous (e.g., in sepsis) and exogenous (via storage for transfusion) RBC injuries. Septic persons with moderate anemia are frequently transfused, but infrequently benefit. Yet conversely any anemia is a negative risk factor. Lung morbidity is frequent after RBC transfusion, possibly due to impaired RBC ability to export ATP, disrupting O2 uptake via pulmonary RBC- endothelial adhesion. We show in septic mice (cecal ligation/puncture, CLP) that the RBC’s ability to produce and export ATP is impaired. We will test the hypothesis that the O2-transport dysfunction in sepsis is mediated in part by impaired export by RBCs of vasoregulatory ATP, a dysfunction compounded by transfused RBCs, exacerbating acute lung injury (ALI) and hypoxemia, by achieving these Aims: Aim 1. Determine the role of RBC ATP export in mortality and ALI in a mouse model of sepsis and transfusion. Exchange transfusion of CLP RBCs into healthy mice exposed to hypoxia drives mortality. RBC ATP export takes place via pannexin 1 (Px1). We will determine the role and mechanism of depressed RBC ATP export via Px1 in the mortality, ALI, and O2 transport responses to sepsis (CLP or severe influenza) and transfusion in mice using genetic and pharmacological approaches. Aim 2. Determine the influence of augmenting transfusate RBC ATP content and/or export on organ function and O2 transport in septic mice. RBC ATP export can be augmented via clinically available approaches: hypoxic RBC storage; transfusate incubation with PIPA (phosphate, inosine, pyruvate, adenine) solution that preserves stored-RBC ATP and DPG; or using an activator of RBC pyruvate kinase (PKR), which augments RBC ATP with little effect on DPG or P50. We will test these approaches to augment or preserve RBC ATP content on ATP export in mice transfused during sepsis. Aim 3. Determine the influence of human sepsis on RBC vasoregulatory function ex vivo, and the functional influence of candidate modulators of ATP content and export in septic RBCs. We validated a novel RBC cryopreservation scheme with superior phenotype fidelity. We built a unique biobank of RBC specimens from septic children and adults. We prospectively sampled over 150 patients with severe sepsis; most subjects have ALI. We will determine the influence of translation-ready lead candidates identified in Aim 2 to augment RBC ATP export on key RBC respiratory functions: vasoactivity, anti-adhesivity, and O2 transport. We will model the effects of transfusate intervention in admixed septic and stored RBCs. Our novel focus on disrupted signaling by RBCs will produce novel, practical, and relevant insight into respiratory dysfunction in sepsis and transfusion.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $649,565 )
2026	2026	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Blood Diseases and Resources Research	001	4	3/24/2026	NON-COMPETING CONTINUATION	$19,884
2026	2026	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Blood Diseases and Resources Research	000	4	2/19/2026	NON-COMPETING CONTINUATION	$629,681
														Subtotal = $649,565

Issue Date FY: 2025 ( Subtotal = $677,158 )
2025	2025	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Blood Diseases and Resources Research	002	3	8/14/2025	NON-COMPETING CONTINUATION	$67,716
2025	2025	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Blood Diseases and Resources Research	000	3	2/19/2025	NON-COMPETING CONTINUATION	$609,442
2025	2025	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Blood Diseases and Resources Research	001	3	4/25/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $677,158

Issue Date FY: 2024 ( Subtotal = $677,450 )
2024	2024	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Blood Diseases and Resources Research	000	2	12/28/2023	NON-COMPETING CONTINUATION	$622,149
2024	2024	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Blood Diseases and Resources Research	001	2	6/20/2024	NON-COMPETING CONTINUATION	$55,301
														Subtotal = $677,450

Issue Date FY: 2023 ( Subtotal = $731,423 )
2023	2023	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Blood Diseases and Resources Research	001	1	5/2/2023	NEW	$0
2023	2023	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Blood Diseases and Resources Research	000	1	3/5/2023	NEW	$731,423
														Subtotal = $731,423

Grand Total All Awards = $2,735,596

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Red blood cell ATP export and transfusion in sepsis

Award Number: R01HL161071

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/05/2023

PERIOD OF PERFORMANCE END DATE: 12/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer